A new Covid-19 vaccine soon to be approved in Australia appears to be even better than all others on offer, with new data showing it could prevent all deaths from the virus.
Trial data from the UK shows the Novavax jab stops 96 per cent of infections and 100 per cent of serious illness and death from the original version of coronavirus.
Australia has ordered 51 million doses of the jab, but it has not yet been approved by regulators.
The vaccine was also about 86 per cent effective in stopping the more contagious UK strain of Covid-19, which has caused havoc in several Australian hotel quarantine systems.
It was about 90 per cent effective overall, combining data from people infected with both versions of the coronavirus.
In a smaller trial conducted in South Africa – where volunteers were primarily exposed to another newer, more contagious variant widely circulating there and spreading around the world – the Novavax vaccine was only around 55 per cent effective at stopping infection but still fully prevented severe illness and death.
Results from the final analysis of the UK trial were largely in line with interim data released in January.
Australia is currently rolling out the Pfizer and AstraZeneca jabs, which are both very effective at stopping serious illness.
People who have received a vaccine can be given another type of jab later if it proves to be a more effective combination.
It comes after Health Department boss Brendan Murphy confirmed all Australians will not get both jabs by October.
But Professor Murphy said a solitary shot of AstraZeneca’s Covid-19 jab – rather than two – will be enough to ‘completely vaccinate’ the population by then.
Speaking on Thursday, Professor Murphy admitted the target of four million vaccinations by next month also won’t be achieved.
He said ‘global supply issues’ with a number of European countries – including Italy blocking the export of a shipment of 250,000 doses to Australia – was the reason for the delay.
Australia had been expecting 3.8 million doses of AstraZeneca vaccine from Europe in March, but so far only 700,000 doses have arrived – leaving a 3.1 million shortfall.
The vaccine was also about 86 per cent effective in stopping the more contagious UK strain of Covid-19, which has caused havoc in several Australian hotel quarantine systems.
It was about 90 per cent effective overall, combining data from people infected with both versions of the coronavirus.
In a smaller trial conducted in South Africa – where volunteers were primarily exposed to another newer, more contagious variant widely circulating there and spreading around the world – the Novavax vaccine was only around 55 per cent effective at stopping infection but still fully prevented severe illness and death.
Results from the final analysis of the UK trial were largely in line with interim data released in January.
Australia is currently rolling out the Pfizer and AstraZeneca jabs, which are both very effective at stopping serious illness.
People who have received a vaccine can be given another type of jab later if it proves to be a more effective combination.
It comes after Health Department boss Brendan Murphy confirmed all Australians will not get both jabs by October.
But Professor Murphy said a solitary shot of AstraZeneca’s Covid-19 jab – rather than two – will be enough to ‘completely vaccinate’ the population by then.
Speaking on Thursday, Professor Murphy admitted the target of four million vaccinations by next month also won’t be achieved.
He said ‘global supply issues’ with a number of European countries – including Italy blocking the export of a shipment of 250,000 doses to Australia – was the reason for the delay.
Australia had been expecting 3.8 million doses of AstraZeneca vaccine from Europe in March, but so far only 700,000 doses have arrived – leaving a 3.1 million shortfall.
Image Credit: Novavax
Post by Amanda Scott, NA CEO. Follow her on twitter @tantriclens
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen
News
Fake Science Is Growing Faster Than Legitimate Research, New Study Warns
New research reveals organized networks linking paper mills, intermediaries, and compromised academic journals Organized scientific fraud is becoming increasingly common, ranging from fabricated research to the buying and selling of authorship and citations, according [...]
Scientists Unlock a New Way to Hear the Brain’s Hidden Language
Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and remember. Scientists have created a new protein that can capture the incoming chemical signals received by brain [...]
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]
We May Never Know if AI Is Conscious, Says Cambridge Philosopher
As claims about conscious AI grow louder, a Cambridge philosopher argues that we lack the evidence to know whether machines can truly be conscious, let alone morally significant. A philosopher at the University of [...]
AI Helped Scientists Stop a Virus With One Tiny Change
Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin. Washington State University scientists have uncovered a method to interfere with a key [...]
Deadly Hospital Fungus May Finally Have a Weakness
A deadly, drug-resistant hospital fungus may finally have a weakness—and scientists think they’ve found it. Researchers have identified a genetic process that could open the door to new treatments for a dangerous fungal infection [...]
Fever-Proof Bird Flu Variant Could Fuel the Next Pandemic
Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body’s main tools for slowing or stopping viral [...]
What could the future of nanoscience look like?
Society has a lot to thank for nanoscience. From improved health monitoring to reducing the size of electronics, scientists’ ability to delve deeper and better understand chemistry at the nanoscale has opened up numerous [...]
Scientists Melt Cancer’s Hidden “Power Hubs” and Stop Tumor Growth
Researchers discovered that in a rare kidney cancer, RNA builds droplet-like hubs that act as growth control centers inside tumor cells. By engineering a molecular switch to dissolve these hubs, they were able to halt cancer [...]
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
Older chemical libraries show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of [...]
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
Tiny Metal Nanodots Obliterate Cancer Cells While Largely Sparing Healthy Tissue
Scientists have developed tiny metal-oxide particles that push cancer cells past their stress limits while sparing healthy tissue. An international team led by RMIT University has developed tiny particles called nanodots, crafted from a metallic compound, [...]
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
